thalidomide has been researched along with Licheniform Eruptions in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scleromyxedema is a generalized, papular, and sclerodermoid form of lichen myxedematosus associated with monoclonal gammopathy and systemic changes." | 5.32 | Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. ( Cocuroccia, B; Girolomoni, G; Gisondi, P; Gubinelli, E; Jorizzo, JL; Sansbury, JC, 2004) |
| "Scleromyxedema is a generalized, papular, and sclerodermoid form of lichen myxedematosus associated with monoclonal gammopathy and systemic changes." | 1.32 | Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. ( Cocuroccia, B; Girolomoni, G; Gisondi, P; Gubinelli, E; Jorizzo, JL; Sansbury, JC, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravichandran, S | 1 |
| Kheterpal, MK | 1 |
| Staumont-Sallé, D | 1 |
| Magro, L | 1 |
| Piette, F | 1 |
| Thomas, P | 1 |
| Jouet, JP | 1 |
| Catteau, B | 1 |
| Caradonna, S | 1 |
| Jacobe, H | 1 |
| Sansbury, JC | 1 |
| Cocuroccia, B | 1 |
| Jorizzo, JL | 1 |
| Gubinelli, E | 1 |
| Gisondi, P | 1 |
| Girolomoni, G | 1 |
4 other studies available for thalidomide and Licheniform Eruptions
| Article | Year |
|---|---|
Apremilast for the off-label treatment of lichenoid and interface dermatoses.
Topics: Aged; Female; Humans; Lichenoid Eruptions; Middle Aged; Off-Label Use; Phosphodiesterase 4 Inhibitor | 2020 |
Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.
Topics: Administration, Oral; Adult; Bone Marrow Transplantation; Diagnosis, Differential; Female; Graft vs | 2003 |
Thalidomide as a potential treatment for scleromyxedema.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Immunosuppr | 2004 |
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
Topics: Aged; Female; Humans; Lichenoid Eruptions; Male; Middle Aged; Myxedema; Paraproteinemias; Scleroderm | 2004 |